Usage of the levonorgestrel releasing intrauterine system in perimenopause.

IF 0.5 Q4 OBSTETRICS & GYNECOLOGY Ceska Gynekologie-Czech Gynaecology Pub Date : 2024-01-01 DOI:10.48095/cccg2024156
Tomáš Fait
{"title":"Usage of the levonorgestrel releasing intrauterine system in perimenopause.","authors":"Tomáš Fait","doi":"10.48095/cccg2024156","DOIUrl":null,"url":null,"abstract":"<p><p>Levonorgestrel releasing intrauterine system have excellent contraceptive efficacy with simultaneous lowering of menstruation's blood loss. It could be used for therapy of endometrial hyperplasia in perimenopause. In position of gestagen part of the hormone replacement therapy it has high control of endometrial proliferation. It is conjoined with the zero increasing of risk of thromboembolic disease in combination with transdermal oestrogen's application.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"89 2","pages":"156-159"},"PeriodicalIF":0.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ceska Gynekologie-Czech Gynaecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48095/cccg2024156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Levonorgestrel releasing intrauterine system have excellent contraceptive efficacy with simultaneous lowering of menstruation's blood loss. It could be used for therapy of endometrial hyperplasia in perimenopause. In position of gestagen part of the hormone replacement therapy it has high control of endometrial proliferation. It is conjoined with the zero increasing of risk of thromboembolic disease in combination with transdermal oestrogen's application.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在围绝经期使用左炔诺孕酮释放宫内避孕系统。
左炔诺孕酮释放型宫内节育器具有良好的避孕效果,并能同时降低月经失血量。它可用于围绝经期子宫内膜增生症的治疗。作为激素替代疗法中孕激素的一部分,它对子宫内膜增生有很强的控制作用。与透皮雌激素结合使用时,血栓栓塞性疾病的风险不会增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ceska Gynekologie-Czech Gynaecology
Ceska Gynekologie-Czech Gynaecology OBSTETRICS & GYNECOLOGY-
CiteScore
0.60
自引率
25.00%
发文量
57
期刊最新文献
Birth plan - legal and medical aspects. Discrepancies in staging and perioperative classification of pelvic endometriosis according to #Enzian 2021. Female orgasm, reproduction and couple relationships. Importance of vaginal packing after laparoscopic sacrocolpopexy - retrospective study. New recommendations for informing patients and gamete donors in assisted reproduction.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1